Frontiers of hypoxia research: acute mountain sickness.

Traditionally, scientists and clinicians have explored peripheral physiological responses to acute hypoxia to explain the pathophysiological processes that lead to acute mountain sickness (AMS) and high-altitude cerebral edema (HACE). After more than 100 years of investigation, little is yet known about the fundamental causes of the headache and nausea that are the main symptoms of AMS. Thus, we review the evidence supporting a change in focus to the role of the central nervous system in AMS. Our justification is (i) that the symptoms of AMS and HACE are largely neurological, (ii) that HACE is considered to be the end-stage of severe AMS and was recently identified as a vasogenic edema, opening the door for a role for blood-brain barrier permeability in AMS, (iii) that new, non-invasive techniques make measurement of brain water levels and cerebral blood volume possible and (iv) that the available experimental evidence and theoretical arguments support a significant role for brain swelling in the pathophysiology of AMS. We believe that an examination of the responses of the central nervous system to acute hypoxia will reveal important new pathophysiological processes that may help explain AMS and HACE.

[1]  P. Hackett High altitude cerebral edema and acute mountain sickness. A pathophysiology update. , 1999, Advances in experimental medicine and biology.

[2]  R. Marchbanks,et al.  Intracranial pressure at high altitude and acute mountain sickness. , 1995, Clinical science.

[3]  R. Wilson Acute high-altitude illness in mountaineers and problems of rescue. , 1973, Annals of internal medicine.

[4]  H. Shimada,et al.  Exercise-induced cerebral deoxygenation among untrained trekkers at moderate altitudes. , 1999, Archives of environmental health.

[5]  R. Gur,et al.  Gender differences in age effect on brain atrophy measured by magnetic resonance imaging. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[6]  R. Kikinis,et al.  Age-related changes in intracranial compartment volumes in normal adults assessed by magnetic resonance imaging. , 1996, Journal of neurosurgery.

[7]  R. Ross THE RANDOM NATURE OF CEREBRAL MOUNTAIN SICKNESS , 1985, The Lancet.

[8]  M. Moskowitz,et al.  High altitude headache. Lessons from headaches at sea level. , 1999, Advances in experimental medicine and biology.

[9]  S. Olesen,et al.  Substances that rapidly augment ionic conductance of endothelium in cerebral venules. , 1986, Acta physiologica Scandinavica.

[10]  J. Krasney A neurogenic basis for acute altitude illness. , 1994, Medicine and science in sports and exercise.

[11]  K. Kubo,et al.  Low pulmonary diffusing capacity in subjects with acute mountain sickness. , 1997, Chest.

[12]  J. West,et al.  Pathogenesis of high-altitude pulmonary oedema: direct evidence of stress failure of pulmonary capillaries. , 1995, The European respiratory journal.

[13]  Hansen Je,et al.  A hypothesis regarding the pathophysiology of acute mountain sickness. , 1970 .

[14]  M. Raichle,et al.  Central neuroendocrine regulation of brain water permeability. , 1978, Ciba Foundation symposium.

[15]  Cyrill Burger,et al.  Changes of Cerebral Blood Flow during Short-Term Exposure to Normobaric Hypoxia , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[16]  P. Hackett,et al.  High-altitude cerebral edema evaluated with magnetic resonance imaging: clinical correlation and pathophysiology. , 1998, JAMA.

[17]  B. Honigman Acute Mountain Sickness in a General Tourist Population at Moderate Altitudes , 1993 .

[18]  Abbott Nj,et al.  Control of brain endothelial permeability. , 1991 .

[19]  T BROMAN,et al.  BRAIN EDEMA. , 1964, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[20]  B. Rosen,et al.  Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors. , 1999, Journal of neurosurgery.

[21]  M. Wahl,et al.  Mediators of cerebral edema. , 1999, Advances in experimental medicine and biology.

[22]  Paul B. Rock,et al.  Acute Mountain Sickness , 1988 .

[23]  M. Yaron,et al.  How well do older persons tolerate moderate altitude? , 1995, The Western journal of medicine.

[24]  C. Houston,et al.  CEREBRAL FORM OF HIGH-ALTITUDE ILLNESS , 1975, The Lancet.

[25]  J. Olesen,et al.  Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomised crossover trial , 1999, The Lancet.

[26]  M. Raichle,et al.  The Effects of Changes in PaCO2 Cerebral Blood Volume, Blood Flow, and Vascular Mean Transit Time , 1974, Stroke.

[27]  H. Hinghofer-Szalkay,et al.  Exercise exacerbates acute mountain sickness at simulated high altitude. , 1999, Journal of applied physiology.

[28]  N. Lassen,et al.  Pathophysiology of acute mountain sickness and high altitude pulmonary oedema: an hypothesis. , 1979, Bulletin europeen de physiopathologie respiratoire.

[29]  M. Wahl,et al.  Brain edema: pathogenesis and therapy. , 1997, Kidney international. Supplement.

[30]  J. Milledge,et al.  High altitude headache: treatment with ibuprofen. , 1994, Aviation, space, and environmental medicine.

[31]  Y. Rong,et al.  Ginkgo biloba attenuates oxidative stress in macrophages and endothelial cells. , 1996, Free radical biology & medicine.

[32]  N. Lassen,et al.  Middle cerebral artery blood velocity and cerebral blood flow and O2 uptake during dynamic exercise. , 1993, Journal of applied physiology.

[33]  S. Pietri,et al.  Ginkgo biloba extract (EGb 761) pretreatment limits free radical-induced oxidative stress in patients undergoing coronary bypass surgery. , 1997, Cardiovascular drugs and therapy.

[34]  W. Schobersberger,et al.  Enhanced exercise-induced rise of aldosterone and vasopressin preceding mountain sickness. , 1991, Journal of applied physiology.

[35]  Merav Cohen,et al.  Regulation of TNF-α by 1α,25-dihydroxyvitamin D3 in human macrophages from CAPD patients , 2001 .

[36]  H. Shenkin,et al.  Clinical methods of reducing intracranial pressure. Role of the cerebral circulation. , 1970, The New England journal of medicine.

[37]  A. Delabays,et al.  Augmented sympathetic activation during short-term hypoxia and high-altitude exposure in subjects susceptible to high-altitude pulmonary edema. , 1999, Circulation.

[38]  D. Heistad,et al.  Role of veins and cerebral venous pressure in disruption of the blood-brain barrier. , 1986, Circulation Research.

[39]  W. Nachbauer,et al.  Aspirin for prophylaxis against headache at high altitudes: randomised, double blind, placebo controlled trial , 1998, BMJ.

[40]  C. Zwillich,et al.  Norepinephrine clearance is increased during acute hypoxemia in humans. , 1991, The American journal of physiology.

[41]  E. Ringelstein,et al.  Relationship of cerebral blood flow regulation to acute mountain sickness. , 1989, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[42]  P. Hackett,et al.  Acetazolamide in the Treatment of Acute Mountain Sickness: Clinical Efficacy and Effect on Gas Exchange , 1992, Annals of Internal Medicine.

[43]  P. Hackett,et al.  THE INCIDENCE, IMPORTANCE, AND PROPHYLAXIS OF ACUTE MOUNTAIN SICKNESS , 1976, The Lancet.

[44]  N. Lassen,et al.  Control of Cerebral Circulation in Health and Disease , 1974, Circulation research.

[45]  A. Marmarou,et al.  Characterization of clinical CSF dynamics and neural axis compliance using the pressure‐volume index: I. The normal pressure‐volume index , 1980, Annals of neurology.

[46]  Arthur R. Bradwell,et al.  Cerebral blood flow in acute mountain sickness. , 1990, Journal of applied physiology.

[47]  Thomas F. Hornbein,et al.  Cerebral Blood Flow In Man at High Altitude: Role of Cerebrospinal Fluid pH in Normalization of Flow in Chronic Hypocapnia , 1966, Circulation research.

[48]  S. Shimojyo,et al.  The effects of graded hypoxia upon transient cerebral blood flow and oxygen consumption , 1968, Neurology.

[49]  I. Spyridopoulos,et al.  Acute mountain sickness is not related to cerebral blood flow: a decompression chamber study. , 1999, Journal of applied physiology.

[50]  M. Meredith,et al.  Intracranial pressures and O2 extraction in conscious sheep during 72 h of hypoxia. , 1991, The American journal of physiology.

[51]  J A Krasney,et al.  Cerebral Blood Flow and Metabolic Responses to Sustained Hypercapnia in Awake Sheep , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[52]  N. Secher,et al.  Middle cerebral artery flow velocity and blood flow during exercise and muscle ischemia in humans. , 1992, Journal of applied physiology.

[53]  Dynamic cerebral autoregulation at high altitude. , 1999, Advances in experimental medicine and biology.

[54]  I. Singh,et al.  Acute mountain sickness. , 1969, The New England journal of medicine.

[55]  M. Tercan,et al.  The effect of Gingko biloba extract (Egb 761) as a free radical scavenger on the survival of skin flaps in rats. A comparative study. , 1998, Scandinavian journal of plastic and reconstructive surgery and hand surgery.

[56]  D. Burge,et al.  Tympanic membrane displacement testing in regular assessment of intracranial pressure in eight children with shunted hydrocephalus. , 1998, Journal of neurosurgery.

[57]  A. Cymerman,et al.  The Effects of Propranolol on Acute Mountain Sickness (AMS) and Well- Being at 4300 Meters Altitude , 1989 .

[58]  H. Wolff,et al.  EXPERIMENTAL STUDIES ON HEADACHE: PAIN-SENSITIVE STRUCTURES OF THE HEAD AND THEIR SIGNIFICANCE IN HEADACHE , 1940 .

[59]  S. Matalon,et al.  Peripheral circulatory responses to 96 hours of eucapnic hypoxia in conscious sheep. , 1985, Respiration Physiology.

[60]  Exercise exacerbates acute mountain sickness at simulated high altitude. , 2000 .

[61]  P. Bärtsch,et al.  [High altitude medicine]. , 2001, Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS.

[62]  N. Lassen,et al.  Increase of Cerebral Blood Flow at High Altitude: Its Possible Relation to AMS , 1992, International journal of sports medicine.

[63]  L. Moore,et al.  Low acute hypoxic ventilatory response and hypoxic depression in acute altitude sickness. , 1986, Journal of applied physiology.

[64]  R L Burse,et al.  Procedures for the measurement of acute mountain sickness. , 1983, Aviation, space, and environmental medicine.

[65]  W. O. Evans,et al.  A hypothesis regarding the pathophysiology of acute mountain sickness. , 1970, Archives of environmental health.

[66]  S. Kety,et al.  THE EFFECTS OF ALTERED ARTERIAL TENSIONS OF CARBON DIOXIDE AND OXYGEN ON CEREBRAL BLOOD FLOW AND CEREBRAL OXYGEN CONSUMPTION OF NORMAL YOUNG MEN. , 1948, The Journal of clinical investigation.

[67]  Charles S. Houston,et al.  THE LAKE-LOUISE ACUTE MOUNTAIN-SICKNESS SCORING SYSTEM , 1993 .

[68]  P. Hackett Mountain sickness : prevention, recognition & treatment , 1980 .

[69]  L. Moore Altitude-aggravated illness: examples from pregnancy and prenatal life. , 1987, Annals of emergency medicine.

[70]  A. Alavi,et al.  Analysis of brain and cerebrospinal fluid volumes with MR imaging. Part I. Methods, reliability, and validation. , 1991, Radiology.

[71]  P. Chan,et al.  Brain injury, edema, and vascular permeability changes induced by oxygen‐derived free radicals , 1984, Neurology.

[72]  P. D'arbigny,et al.  EGb 761 in control of acute mountain sickness and vascular reactivity to cold exposure. , 1996, Aviation, space, and environmental medicine.

[73]  J. Mitchell,et al.  Cerebral blood flow during submaximal and maximal dynamic exercise in humans. , 1989, Journal of applied physiology.

[74]  R P Velthuizen,et al.  MRI segmentation: methods and applications. , 1995, Magnetic resonance imaging.

[75]  B. Levine,et al.  Dexamethasone in the treatment of acute mountain sickness. , 1989, The New England journal of medicine.

[76]  F. S. Wright,et al.  Pulmonary artery pressure and alveolar gas exchange in man during acclimatization to 12,470 ft. , 1971, The Journal of clinical investigation.

[77]  N. Wahlgren,et al.  Carotid artery blood flow and middle cerebral artery blood flow velocity during physical exercise. , 1996, Journal of applied physiology.

[78]  P. Weidmann,et al.  Atrial natriuretic peptide in acute mountain sickness. , 1988, Journal of applied physiology.

[79]  K. Kubo,et al.  Clinical features of patients with high-altitude pulmonary edema in Japan. , 1987, Chest.

[80]  J. Patterson,et al.  Cerebrovascular response to acute hypocapnic and eucapnic hypoxia in normal man. , 1970, The Journal of clinical investigation.

[81]  Cerebral metabolic and pressure-flow responses during sustained hypoxia in awake sheep. , 1991, Journal of applied physiology.

[82]  R. Roach,et al.  Acute mountain sickness and acetazolamide. Clinical efficacy and effect on ventilation. , 1982, JAMA.

[83]  H. Wolff Headache and Other Head Pain , 1972 .